Crossmark

Activation-induced deaminase and its splice variants associate with trisomy 12 in chronic lymphocytic leukemia

Crossref DOI link: https://doi.org/10.1007/s00277-018-3520-5

Published Online: 2018-10-27

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zaprazna, Kristina

Reblova, Kamila

Svobodova, Veronika

Radova, Lenka

Bystry, Vojtech

Baloun, Jiri

Durechova, Kristina

Tom, Nikola

Loja, Tomas

Buresova, Martina

Stranska, Kamila

Oltova, Alexandra

Doubek, Michael

Atchison, Michael L.

Trbusek, Martin

Malcikova, Jitka

Pospisilova, Sarka
Funding

Funding for this research was provided by:

JCMM - Somopro (No. 3SGA5792)

MEYS CR (CEITEC 2020 (LQ1601), LM2011020)
License Information

Text and Data Mining valid from 2018-10-27
More Information

Article History

Received: 20 May 2018

Accepted: 9 October 2018

First Online: 27 October 2018

Compliance with ethical standards

: The study was performed on peripheral blood samples taken with written informed consent provided in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008. All animal studies were performed in compliance with the U.S. Department of Health and Human Services guidelines and were approved by the University of Pennsylvania Institutional Animal Care and Use Committee.

: The authors declare that they have no conflict of interest.